trending Market Intelligence /marketintelligence/en/news-insights/trending/ou3bcxmhc2g-rp_jn88ldg2 content esgSubNav
In This List

Dr. Reddy's Laboratories director resigns

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond


Dr. Reddy's Laboratories director resigns

Hans Peter Hasler has resigned as director of Dr. Reddy's Laboratories Ltd., effective June 14, to engage in a business opportunity which could pose a potential conflict of interest with his position at the company.

Hasler served as an independent director of the company since 2016.

India-based Dr. Reddy's Laboratories operates as an integrated pharmaceutical company worldwide.